NEW YORK, NY, May 08, 2013 (Press-News.org) InfoTech, a leading software house and system solutions company, has completed and delivered CBDC with a customized white labeled version of the Diverse Director Data Source system (also known as 3D) to support CBDC's Diversity 50 2013 Application process.
The Diversity 50 is a brand new resource for directors and search firms. It is Canada's first-ever database of qualified diverse men and women from across Canada with strong competencies that align with the requirements of many Canadian boards (www.boarddiversity.ca/diversity-50).
The customized solution also includes a public view of all the Diversity 50 winners from all previous years as well as a customized "Candidate Search" feature that allows authorized users to search through the current year's approved candidate's pool. This customization solution improves the Diversity 50 application process as well as the monitoring of the approved candidates.
Peter Housley, CBDC's CMO stated, "The new application delivered by InfoTech provides Canadian Board candidates the ability to register directly via the Web to the Diversity 50 2013 program, bypassing the long and tedious process of mail registration." Mr. Housley added, "We always enjoy working with InfoTech, their products are consistently developed on time and within budget."
Matti Kon, InfoTech's President and CEO stated "We are thankful for the opportunity to work with a company like CBDC which is driven by the pursuit of diversity for the business community in Canada." Mr. Kon added, "It has been a pleasure to work with CBDC and we look forward to working with them on additional opportunities in the future."
About InfoTech Solutions for Business, Inc.
InfoTech Solutions for Business, Inc. (InfoTech) is a privately owned software house and system integration company with a variety of products, IT services and business practices. Headquartered in midtown Manhattan, with satellite offices in the U.S. only, InfoTech is a Microsoft Certified Partner and GSA approved contractor with multiple credentials and certifications.
InfoTech specializes in custom software development and serves its clients via the following business practices and services, as well as the following software product lines:
InfoTech's Business Practices/Services
Custom Application Development
Federal/DoD Practice
IT Outsourcing (Onsite, Hosting & Cloud)
Social Media Systems
InfoTech's Software Product Lines
RPAS - Financial Systems
MMS - Marketing Systems
WRS - Labor Management Systems
SD - Security Compliance Systems
The company's clients include some of the most prestigious banks, media companies, government agencies, and small to mid-size companies representing a wide range of industries. Additional information can be found at www.infotechfb.com or by contacting InfoTech at (212) 245-4222.
About the Canadian Board Diversity Council
The Council is the leading Canadian organization advancing diversity on Canada's boards. Founded in 2009, the Council has since grown to 52 Founding and Corporate Member organizations that are committed to greater diversity in the Canadian workplace. The Council's goal is to improve the diversity of Canada's corporate boards by increasing the representation of women, visible minorities, Aboriginal Peoples including First Nations, Inuit and Metis, persons with disabilities and members of the LGBT community.
The Council's call to action to boards and shareholders is i) appoint at least one diverse director for every three directors retiring and ii) consider three diverse candidates when identifying each new potential director and iii) identify and sponsor
board-ready diverse candidates.
For more information, please visit www.boarddiversity.ca
Canadian Board Diversity Council (CBDC) Chooses InfoTech Solutions for Business for the Diversity 50 2013 Application Process Project
InfoTech has completed and delivered CBDC with a customized white labeled version of the Diverse Director Data Source system (also known as 3D) to support CBDC's Diversity 50 2013 application process.
2013-05-08
ELSE PRESS RELEASES FROM THIS DATE:
New class of drug targets skin cancer
2013-05-07
7 May, 2013 -- Sydney, Australia:
A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.
The research involves the drug Dz13, a targeted molecular therapy, which was developed at the University of New South Wales (UNSW) and has now been found to be safe in a clinical trial of patients with the common skin cancer, basal-cell carcinoma.
"This is the first report of a drug of this type to be used in humans," ...
New perspective needed for role of major Alzheimer's gene
2013-05-07
Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found.
People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer's disease compared with those who have other variations of the gene.
Many researchers believe that the memory loss and cognitive problems of Alzheimer's result from the buildup over many years of brain amyloid plaques. The plaques are made mostly of a sticky substance called amyloid ...
A giant leap to commercialization of polymer solar cell
2013-05-07
A polymer solar cell is a type of thin film solar cells made with polymers that produce electricity from sunlight by the photovoltaic effect. Most current commercial solar cells are made from a highly purified silicon crystal. The high cost of these silicon solar cells and their complex production process has generated interest in developing alternative photovoltaic technologies.
Compared to silicon-based devices, PSCs are lightweight (which is important for small autonomous sensors), solution processability (potentially disposable), inexpensive to fabricate (sometimes ...
New insights into Ebola infection pave the way for much-needed therapies
2013-05-07
The Ebola virus is among the deadliest viruses on the planet, killing up to 90% of those infected, and there are no approved vaccines or effective therapies. A study published by Cell Press on May 7th in the Biophysical Journal reveals how the most abundant protein making up the Ebola virus—viral protein 40 (VP40)—allows the virus to leave host cells and spread infection to other cells throughout the human body. The findings could lay the foundation for the development of new drugs and strategies for fighting Ebola infection.
"Little research is available on how the ...
Protecting the heart health of diabetic patients
2013-05-07
Diabetics have an increased risk of developing coronary artery disease and plaque build-up in their arteries, even if they receive cholesterol-lowering therapies. New research published in the May 7th issue of the Cell Press journal Cell Metabolism reveals that high blood sugar levels also boost the production of inflammatory cells, which contribute to plaque build-up in blood vessels. The researchers identify the cause of this increased production in inflammatory cells and find that blocking this new pathway could help safeguard the heart health of diabetic patients.
"We ...
Biomechanical performances of old-fashioned leather and modern football helmets
2013-05-07
Charlottesville, VA (May 7, 2013). Researchers at the Center for Injury Biomechanics at Virginia Tech in Blacksburg, Virginia compared the relative safety afforded by two 1930-vintage leather football helmets and 10 modern football helmets during impacts to players' heads. These researchers found that all 10 modern helmets provided significantly more protection than leather helmets used in the first half of the twentieth century, and demonstrated that differences also exist between modern helmets. Details on their methods and findings are found in "Biomechanical performance ...
Type 1 diabetes and heart disease linked by inflammatory protein
2013-05-07
NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes. Led by Columbia University Medical Center (CUMC) researchers in collaboration with investigators at New ...
Study of new 'bone-head' hints at higher diversity of small dinosaurs
2013-05-07
Toronto, Canada – Scientists have named a new species of bone-headed dinosaur (pachycephalosaur) from Alberta, Canada. Acrotholus audeti (Ack-RHO-tho-LUS) was identified from both recently discovered and historically collected fossils. Approximately six feet long and weighing about 40 kgs in life, the newly identified plant-eating dinosaur represents the oldest bone-headed dinosaur in North America, and possibly the world. Research describing the new species is published May 7, 2013 in the journal Nature Communications.
Acrotholus means "high dome", referring to its ...
ASTRO and AUA issue joint guideline for radiation therapy after prostatectomy
2013-05-07
San Diego, May 7, 2013 – The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence. The 81-page document represents an intensive collaboration among experts in the radiation oncology and urology fields, led by Richard K. Valicenti, MD, MA, professor and chair of the department of radiation oncology at the University of California Davis Comprehensive Cancer Center ...
Discovery of new hormone opens doors to new type 2 diabetes treatments
2013-05-07
Boston, MA — Harvard School of Public Health (HSPH) researchers have discovered that a particular type of protein (hormone) found in fat cells helps regulate how glucose (blood sugar) is controlled and metabolized (used for energy) in the liver. Using experimental models and state-of-the-art technology, the scientists found that switching off this protein leads to better control of glucose production from the liver, revealing a potential new target that may be used to treat type 2 diabetes and other metabolic diseases.
The study appears online in the May 7, 2013 issue ...
LAST 30 PRESS RELEASES:
Astronomers detect radio signals from a black hole tearing apart a star – outside a galactic center
Locking carbon in trees and soils could help ‘stabilize climate for centuries’ – but only if combined with underground storage
New research shows a tiny, regenerative worm could change our understanding of healing
Australia’s rainforests first to switch from carbon sink to source
First-trimester mRNA COVID-19 vaccination and risk of major congenital anomalies
Glucose-lowering medication classes and cardiovascular outcomes in patients with type 2 diabetes
Rising seas and sinking cities signal a coastal crisis in China
Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome
Study indicates dramatic increase in percentage of US adults who meet new definition of obesity
Astrocytes are superstars in the game of long-term memory
WSU study finds positive framing can steer shoppers toward premium products
Study finds ending universal free school meals linked to rising student meal debt and stigma
Innovations in organoid engineering: Construction methods, model development, and clinical translation
Rescheduling coca: Aligning global drug policy with science, tradition, and indigenous rights
BIOFAIR roadmap for an integrated biological and environmental data network
SwRI, 8 Rivers patent more cost-effective, efficient power generation system with liquid oxygen storage
A sacred leaf on trial: Scientists urge WHO to support decriminalizing coca
World’s largest superconducting fusion system will use American technology to measure the plasma within
Mount Sinai receives $4.5 million NIH award to launch a pioneering women’s environmental health research training program
Strong grip strength may protect against obesity-related complications
How to double lung cancer screening rates
Researchers ‘zoom’ in for an ultra-magnified peek at shark skin
AI system finds crucial clues for diagnoses in electronic health records
Gut microbiota disruption predicts severe steatosis in MASLD patients
WSU project reduces hospitalizations among home health-care patients
Rain in the Sahara? UIC researchers predict a wetter future for the desert
Solar-powered lights keep sea turtles out of fishing nets
A prototype glucose battery inspired by the body’s metabolism
A triple-threat iron supplement that also improves gut health
TTUHSC researcher awarded CPRIT grant to study type of pediatric bone cancer
[Press-News.org] Canadian Board Diversity Council (CBDC) Chooses InfoTech Solutions for Business for the Diversity 50 2013 Application Process ProjectInfoTech has completed and delivered CBDC with a customized white labeled version of the Diverse Director Data Source system (also known as 3D) to support CBDC's Diversity 50 2013 application process.